[ Price : $8.95]
FDA warns Joliet, IL-based TJA Health about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
FDA warns Fort Worth, TX-based Quality CDMO that it is marketing five unapproved new drugs.[ Price : $8.95]
PhRMA asks FDA to consider a phased approach to enforcing the Drug Supply Chain Security Act because many drug company trading par...[ Price : $8.95]
FDA approves an expanded use for Novartis Kisqali (ribociclib) combination use with an aromatase inhibitor for the adjuvant treat...[ Price : $8.95]
FDA lifts a partial clinical hold against Vigil Neuroscience and its ongoing Phase 1 clinical trial of VG-3927, a small molecule t...[ Price : $8.95]
In an untitled letter, FDA says Milan, Italy-based Industria Farmaceutica is manufacturing drugs with CGMP violations.[ Price : $8.95]
Merck and Daiichi Sankyo say their HERTHENA-Lung02 Phase 3 trial evaluating patritumab deruxtecan in certain patients with locally...[ Price : $8.95]
Federal Register notice: FDA announces an 11/20-21 Digital Health Advisory Committee meeting to discuss generative artificial inte...